Shareholding disclosure

OSI Pharmaceuticals, Inc

Declared position

5.33%

Threshold

Crossed upwards

Timeline

Published

21.11.2009

Transaction

18.11.2009

Transfer date

18.11.2009

Voting rights breakdown

Voting rights acquired5.33%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA9BK00019

Beneficial owner

OSI Pharmaceuticals, Inc

Declared address

OSI Pharmaceuticals, Inc., Melville, NY 11747

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

OSI Pharmaceuticals, Inc

HBM Healthcare Investments AG21.11.2009TA9BK00019

Disclosure summary

OSI Pharmaceuticals, Inc disclosed a holding in HBM Healthcare Investments AG on the acquisition side, published by SIX Exchange Regulation on 21.11.2009, at 5.33% of voting rights. Notice category: Single shareholder.

Disclosed position

5.33%

Voting rights acquired

Voting rights acquired5.33%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

OSI Pharmaceuticals, Inc disclosed a holding in HBM Healthcare Investments AG, published on 21.11.2009.

Publication date21.11.2009

Transaction date18.11.2009

Transfer date18.11.2009

Issuing companyHBM Healthcare Investments AG

Beneficial ownerOSI Pharmaceuticals, Inc

Declared addressOSI Pharmaceuticals, Inc., Melville, NY 11747

CategorySingle shareholder

Voting rights acquired5.33%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA9BK00019

Source: SIX Exchange Regulation · Publication date: 21.11.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open